BBIO
BridgeBio Pharma, Inc.Company with tickers: BBIO
CIK
1743881
CUSIP
10806X102
Shares Outstanding
195,861,242
13F Activity (30d)
253 filings
248 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2022-05-10 | 2022-05-05 | |
| 8-K | 2022-05-13 | 2022-05-12 | |
| 8-K | 2022-05-18 | 2022-05-12 | |
| 8-K | 2022-06-24 | 2022-06-22 | |
| 8-K | 2022-07-26 | — | |
| 8-K | 2022-08-04 | — | |
| 10-Q | 2022-08-04 | 2022-06-30 | |
| 8-K | 2022-09-23 | — | |
| 8-K | 2022-11-03 | — | |
| 10-Q | 2022-11-03 | 2022-09-30 | |
| 8-K | 2022-12-06 | 2022-11-30 | |
| 8-K | 2023-02-23 | 2023-02-21 | |
| 10-K | 2023-02-23 | 2022-12-31 | |
| 8-K | 2023-03-06 | — | |
| 8-K | 2023-03-09 | 2023-03-07 | |
| 8-K | 2023-05-04 | 2023-05-03 | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| 8-K | 2023-05-04 | — | |
| 8-K | 2023-06-22 | 2023-06-21 | |
| 8-K | 2023-07-17 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-09-25 | — | |
| 8-K | 2023-11-02 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-18 | 2024-01-17 | |
| 10-K | 2024-02-22 | 2023-12-31 | |
| 8-K | 2024-02-22 | — | |
| 8-K | 2024-03-04 | 2024-03-01 | |
| 8-K | 2024-03-06 | 2024-03-05 | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| 8-K | 2024-05-02 | — | |
| 8-K | 2024-06-06 | 2024-06-04 | |
| 8-K | 2024-06-24 | 2024-06-21 | |
| 8-K | 2024-07-23 | — | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-08-21 | 2024-08-16 | |
| 8-K | 2024-09-11 | 2024-09-10 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-25 | 2024-11-22 | |
| 8-K | 2025-01-13 | — | |
| 10-K | 2025-02-20 | 2024-12-31 | |
| 8-K | 2025-02-20 | — | |
| 8-K | 2025-02-28 | 2025-02-24 | |
| 8-K | 2025-03-17 | — | |
| 10-Q | 2025-04-29 | 2025-03-31 | |
| 8-K | 2025-04-29 | — |
Showing 51–100 of 118 filings